People

Pulmatrix has announced that Robert Clarke will succeed Robert Connelly as the company’s Chief Executive Officer. Clarke has been with the company, which is developing inhaled drugs based on its proprietary iSPERSE (inhaled small particles… Read more . . .

Hovione has named Mike Ironside as General Manager of its Technology Transfer Center (TTC), which is located in New Jersey. Ironside was most recently with Anacor Pharmaceuticals and has previously worked for GSK and AMRI.… Read more . . .

Particle manufacturing specialist Liquidia Technologies has named Benjamin Yerxa, most recently at Clearside Biomedical, as its new Chief Scientific Officer. Yerxa will oversee R&D, “including a focus on scientific collaborations,” for the company. Liquidia’s PRINT… Read more . . .

Hovione has announced the appointment of Conrad Winters as Director, Drug Product Development. Winters most recently was Senior Director of the Compound Properties Group at Xenon Pharmaceuticals and previously held positions with Merck. Hovione VP… Read more . . .

Inhaled drug company Alexza Pharmaceuticals has announced the promotions of four executives. The company has promoted James V. Cassella to Executive VP, Research and Development and Chief Scientific Officer; Darl Moreland to Senior VP, Quality;… Read more . . .

Indian pharmaceutical company Cipla has hired former Teva vice-president Frank Pieters as Head of European Business and Head of Global Respiratory Business. Pieters was most recently Senior VP for the Region of Southern Europe at… Read more . . .

Insmed Incorporated, which is developing Arikace liposomal amikacin for inhalation, has appointed Donald J. Hayden, Jr. as Executive Chairman of its Board of Directors, effective immediately. He has been serving as Chairman of the board… Read more . . .

Mark Shepherd, Respiratory Physics Lab and Workshop Manager at Team Consulting, will attempt to set a world record by climbing to the top of the Empire State Building in New York City while carrying 125… Read more . . .

The University of Western Ontario has named particle technology researcher Jesse Zhu a 2012 Distinguished University Professorship winner. Zhu, a professor and Canada Research Chair in Powder Technology Applications in the Department of Chemical and… Read more . . .

Hovione has appointed Colin Minchom, formerly Patheon’s VP of Pharmaceutical Development Services for North America, as VP of its Particle Design Business Unit. Minchom has almost 30 years experience in drug development, especially in dosage… Read more . . .